• 1
    Wright PF, Neumann G, Kawaoka Y. Orthomyxoviruses; in KnipeDM, HowleyPM (eds): Fields Virology. 5th edn. Philadelphia: Lippincott Williams & Wilkins, 2007; 16911740.
  • 2
    Dawood FS, Jain S, Finelli L et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:26052615.
  • 3
    WHO. World now at the start of 2009 influenza pandemic. 2009 June 11; Available at (Accessed 15 June 2009).
  • 4
    WHO. Pandemic (H1N1) 2009 – update 85. 2010 Available at (Accessed 2 February 2010).
  • 5
    Garten RJ, Davis CT, Russell CA et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325:197201.
  • 6
    Dunham EJ, Dugan VG, Kaser EK et al. Different evolutionary trajectories of European avian-like and classical swine H1N1 influenza A viruses. J Virol 2009; 83:54855494.
  • 7
    Qi L, Kash JC, Dugan VG et al. Role of sialic acid binding specificity of the 1918 influenza virus hemagglutinin protein in virulence and pathogenesis for mice. J Virol 2009; 83:37543761.
  • 8
    Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27:493497.
  • 9
    Szretter KJ, Balish AL, Katz JM. Influenza: propagation, quantification, and storage; in Coico R, (ed): Current Protocols in Microbiology. Hoboken, NJ: John Wiley and Sons, 2007; 15G.1.1G.1.22.
  • 10
    Brownlee GG, Fodor E. The predicted antigenicity of the haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin. Philos Trans R Soc Lond B Biol Sci 2001; 356:18711876.
  • 11
    Taubenberger JK, Reid AH, Janczewski TA, Fanning TG. Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Philos Trans R Soc Lond B Biol Sci 2001; 356:18291839.
  • 12
    Morens DM, Taubenberger JK, Fauci AS. The persistent legacy of the 1918 influenza virus. N Engl J Med 2009; 361:225229.
  • 13
    CDC. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009; 58:521524.
  • 14
    CDC. 2009 pandemic influenza A (H1N1) virus infections – Chicago, Illinois, April–July 2009. MMWR Morb Mortal Wkly Rep 2009;58:913918.
  • 15
    Kelly HA, Grant KA, Williams S, Fielding J, Smith D. Epidemiological characteristics of pandemic influenza H1N1 2009 and seasonal influenza infection. Med J Aust 2009; 191:146149.
  • 16
    Baker MG, Wilson N, Huang QS et al. Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill 2009; 14:pii:19319.
  • 17
    Vaillant L, La Ruche G, Tarantola A, Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 2009; 14:pii:19309.
  • 18
    Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998; 178:5360.
  • 19
    Hancock K, Veguilla V, Lu X et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:19451952.
  • 20
    Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 1982;31(2 Pt 1):417427.
  • 21
    Fitch WM, Leiter JM, Li XQ, Palese P. Positive Darwinian evolution in human influenza A viruses. Proc Natl Acad Sci USA 1991; 88:42704274.
  • 22
    Itoh Y, Shinya K, Kiso M et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009; 460:10211025.
  • 23
    Collins SD. Influenza–pneumonia mortality in a group of about 95 cities in the United States, 1920–1929. Public Health Rep 1930; 45:361406.
  • 24
    Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Basler CF. Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci USA 2004; 101:31663171.
  • 25
    Langmuir AD, Serfling RE, Shermann IL, Dauer CC, Epidemiology Branch CDC. The epidemiology of Asian influenza 1957–1960: a descriptive brochure; in Communicable Disease Center (ed.) Atlanta: U.S. Department of Health E, and Welfare, Public Health Serivce, Communicable Disease Center 1960, 120.
  • 26
    CDC. Novel H1N1 flu: facts and figures. 2009 August 4; Available at (Accessed 21 September 2009).
  • 27
    Sencer DJ, Millar JD. Reflections on the 1976 swine flu vaccination program. Emerg Infect Dis 2006; 12:2933.
  • 28
    Nguyen HH, Moldoveanu Z, Novak MJ et al. Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues. Virology 1999; 254:5060.
  • 29
    Kreijtz JH, Bodewes R, Van Amerongen G et al. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Vaccine 2007; 25:612620.
  • 30
    Powell TJ, Strutt T, Reome J et al. Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus. J Immunol 2007; 178:10301038.
  • 31
    Quan FS, Compans RW, Nguyen HH, Kang SM. Induction of heterosubtypic immunity to influenza virus by intranasal immunization. J Virol 2008; 82:13501359.
  • 32
    Kreijtz JH, Bodewes R, Van Den Brand JM et al. Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus. Vaccine 2009; 27:49834989.
  • 33
    Imperato PJ. The United States swine influenza immunization program: a New York City perspective. Bull N Y Acad Med 1979; 55:285302.
  • 34
    Bureau USC. 2008 National Population Projections. 2008 Available at (Accessed 22 September 2009).